alexa Editor - Ourania Kostopoulou | Karolinska University Hospital | 26048

Journal of Microbial Pathogenesis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Ourania Kostopoulou

Ourania Kostopoulou
Ourania Kostopoulou
Department of Medicine
Center for Molecular Medicine (CMM)
Karolinska University Hospital


She obtained my PhD degree in Basic Medical Sciences, Department of Biochemistry, School of Medicine University of Patras. Title of thesis: Derivatives of chloramphenicol as antibacterial and anticancer agents and as tools to study the function of the catalytic center of the ribosome. At the beginning of my PhD I got a fellowship in the framework of a DAAD/IKYDA programme for training in Gene Center, LMU, Munich, Adviser Prof. Daniel Wilson. I participated also in the ARISTEIA “Excellence” programme of General Secretariat of Research and Technology. Title of the Project: Dissecting the involvement and the dynamic networks of tRNA expression, signaling and translation in lung cancer. I have co-authored 12 publications in peer reviewed journals including Nucleic acid Research, International Journal of Cancer, Oncotarget, Journal of Virology, PLOS ONE. Now I am working as Postdoctoral Researcher in Karolinska University Hospital studying the effect of HCMV infection in ribosomal biogenesis.

Research Interest

Ribosome, protein synthesis, development of new antiviral (especially HCMV), anticancer drugs

Leave Your Message 24x7